Epstein Secrets

t listed for each compound represents the lowest concentration of the compound that will be reported as being positive. If the compound is listed as None Detected, It Is not present above the Reporting Limit. Please refer to the Positive Findings section of the report for those compounds that were identified a

L ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 ng/mL MMB-FUBINACA 0.10 ng/mL ADMB-FUBINACA 1.0 nglmL NA-FUBIC 1.0 ng/mL AMB-CHMINACA 1.0 nglmL NA-FUBIM 0.20 ng/mL Rot. Limit Compound Rot. Limit NMS v.18.0 EFTA00130085 THE CITY OF NEW YORK OFFICE OF CHIEF MEDICAL EXAMINER

t listed for each compound represents the lowest concentration of the compound that will be reported as being positive. If the compound is listed as None Detected, it is not present above the Reporting LM'iit. Please refer to the Positive Findings section of the report for those compounds that were identified

ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 rig/mt. MMB-FUBINACA 0.10 ng/mL ADMB-FUBINACA 1.0 ng/mL NA-FUBIC 1.0 ng/mL AMB-CHMINACA 1.0 ng/mL NA•FUBIM 0.20 ng/mL NMS v.18.0 EFTA00063528 THE CITY OF NEW YORK OFFICE OF CHIEF MEDICAL EXAMINER NEUROPATHOLOGY REPORT CASE NUMB

t listed for each compound represents the lowest concentration of the compound that will be reported as being positive. If the compound is listed as None Detected, it is not present above the Reporting Limit Please refer to the Positive Findings section of the report for those compounds that were identified as

L ADMB-CHMINACA 0.10 ng/ml MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 ng/mL MMB-FUBINACA 0.10 ng/ml ADMB-FUBINACA 1.0 ng/mL NA-FUBIC 1.0 ng/ml AMB-CHMINACA 1.0 ng/mL NA-FUBIM 0.20 ng/ml NMSv.18.0 Page 3243 THE CITY OF NEW YORK OFFICE OF CHIEF MEDICAL EXAMINER NEUROPATHOLOGY REPORT CASE NUMBER:

t listed for each compound represents the lowest concentration of the compound that will be reported as being positive. If the compound Is listed as None Detected, it is not present above the Reporting Limit Please refer to the Positive Findings section of the report for those compounds that were identified as

L ADMB-CHMINACA 0.10 ng/mL MMB-FUBICA 1.0 ng/mL ADMB-FUBICA 1.0 ng/mL MMB-FUBINACA 0.10 ng/mL ADMB-FUBINACA 1.0 ng/mL NA-FUBIC 1.0 ng/mL AMB-CHMINACA 1.0 ng/mL NA-FUBIM 0.20 ng/mL NMS v.18.0 EFTA00133089 EFTA00133090 THE CITY OF NEW YORK OFFICE OF CHIEF MEDICAL EXAMINER NEUROPATHOLOGY RE